Gene-Targeted prostate screening study aims to uncover cancer risks
NCT ID NCT00261456
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 37 times
Summary
This study looks at whether men with certain inherited gene changes (BRCA1, BRCA2, or mismatch repair genes) have a higher chance of getting prostate cancer. About 3,500 men aged 40-69 with or without these gene changes will get yearly PSA tests. The goal is to learn how often prostate cancer is found in these groups and improve screening for those at higher genetic risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Genetics Unit, Royal Marsden Hospital
Sutton, Surrey, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.